🧪
hypothesis

Test hypothesis 2

Hypothesis

Test hypothesis 2

🎯 Composite 30%💱 $0.50▼36.4%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 0 support 0 oppose
⚠ Missing Evidence⚠ No Target Gene⚠ Thin Description⚠ Orphaned Senate Quality Gates →
☰ Compare⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite30%

🧪 Overview

No data yet for this section.

🧬 Mechanism

No curated mechanism pathway recorded for this hypothesis.

⚖️ Evidence

No supporting or contradicting evidence recorded yet.
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

No DepMap CRISPR Chronos data found for this gene.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0097
Events (7d)
0
Price History
▼36.4%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF the biomarker levels are measured and stratified by disease severity, THEN a monotonic increase or decrease in biomarker concentration will be observed across severity groups within the cross-sectiLinear trend in biomarker levels across severity tiers with Spearman correlation coefficient > 0.4— no observation —pending0.50
IF participants receive the experimental intervention versus control, THEN the primary outcome measure will show a statistically significant difference in the expected direction within 12 weeks.Effect size of at least 0.5 standard deviations between intervention and control groups on the primary measurable endpoint— no observation —pending0.50
🔮 Falsifiable Predictions (2)
pendingconf 50%
IF participants receive the experimental intervention versus control, THEN the primary outcome measure will show a statistically significant difference in the expected direction within 12 weeks.
Predicted outcome: Effect size of at least 0.5 standard deviations between intervention and control groups on the primary measurable endpoint
Falsification: No statistically significant difference between groups (p > 0.05) or effect size < 0.3 SD after 12 weeks of intervention
pendingconf 50%
IF the biomarker levels are measured and stratified by disease severity, THEN a monotonic increase or decrease in biomarker concentration will be observed across severity groups within the cross-sectional assessment.
Predicted outcome: Linear trend in biomarker levels across severity tiers with Spearman correlation coefficient > 0.4
Falsification: No significant trend observed (Spearman ρ < 0.2) or non-monotonic pattern inconsistent with hypothesis direction
View on SciDEX ↗